WO2025003130 - DENDRITIC CELLS LOADED WITH LYSATES FROM LATE FERROPTOTIC CELLS TO TREAT CANCER
National phase entry is expected:
Publication Number
WO/2025/003130
Publication Date
02.01.2025
International Application No.
PCT/EP2024/067800
International Filing Date
25.06.2024
Title **
[English]
DENDRITIC CELLS LOADED WITH LYSATES FROM LATE FERROPTOTIC CELLS TO TREAT CANCER
[French]
CELLULES DENDRITIQUES CHARGÉES DE LYSATS PROVENANT DE CELLULES FERROPTIQUES TARDIVES POUR LE TRAITEMENT DU CANCER
Applicants **
UNIVERSITEIT GENT
Sint-Pietersnieuwstraat 25
9000 Gent, BE
Inventors
KRYSKO, Dmitri V.
Cell Death Investigation and Therapy (CDIT) Laboratory
Anatomy and Embryology Unit
Department of Human Structure and Repair
C. Heymanslaan 10, 4B3, Ingang 46
9000 Gent, BE
SAVIUK, Mariia
Cell Death Investigation and Therapy (CDIT) Laboratory
Anatomy and Embryology Unit
Department of Human Structure and Repair
C. Heymanslaan 10, 4B3, Ingang 46
9000 Gent, BE
Priority Data
23182755.1
30.06.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1091 | |
| EPO | Filing, Examination | 4733 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9704 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to the field of immunotherapeutical compositions which can be used to treat cancer. More in particular, the present invention discloses dendritic cells loaded with lysates derived from late ferroptotic cancer cells which are useful to treat cancer.[French]
La présente invention se rapporte au domaine de compositions immunothérapeutiques qui peuvent être utilisées pour le traitement du cancer. Plus particulièrement, la présente invention divulgue des cellules dendritiques chargées de lysats dérivés de cellules cancéreuses ferroptotiques tardives qui sont utiles pour le traitement du cancer.